This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended July 2025 · cache
25 of 47 declarations
Devonian Health Group Inc. is a Canadian health company listed on the Toronto stock exchange. Its known market capitalisation is CAD 19,744,148, with 12% held by insiders. There are 47 filings on record, published from May 18, 2017 to February 21, 2024, by 15 filers; none falls in the last twelve months.
No open-market sale appears. Nine purchases total EUR 18,143, median EUR 975, and director Sybil Dahan accounts for most of them: 8 purchases among 10 filings. The biggest sums are EUR 6,944 on May 29, 2018, then EUR 5,105 and EUR 1,169, both on April 16, 2021. Between April 16 and April 20, 2021, two filers bought EUR 9,377 together, the busiest window.
Most of the file, 37 filings, is of a nature other than an open-market purchase or sale, plus one option exercise. Director Jacques Bernier tops the filers with 12 filings, none a purchase or a sale, and Aspri Pharma Canada Inc., a holder of more than 10% of the securities, has 7. 2018 is the busiest year with 12 filings, ahead of 2021 with 11. Publication takes a median of 4 days after the trade.